
Bigfoot Biomedical, which is focused on creating better health outcomes for people with insulin-requiring diabetes, has raised $57 million in funding. The investor was Madryn Asset Management LP.
Source: Press Release
Bigfoot Biomedical, which is focused on creating better health outcomes for people with insulin-requiring diabetes, has raised $57 million in funding.
Bigfoot Biomedical, which is focused on creating better health outcomes for people with insulin-requiring diabetes, has raised $57 million in funding. The investor was Madryn Asset Management LP.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination